stockrowEli Lilly and Company
LLY Healthcare Drug Manufacturers General
Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +16.3%
- Free cash flow
- +21.8%
- Total debt
- +15.0%
Quarter to September 2026, against a year earlier
Follow LLY
Alert me
Eli Lilly and Company (LLY) Gross margin
Eli Lilly and Company's gross margin over the twelve months to 30 September 2026 was 83.6%, up 0.6 percentage points from fiscal 2025 (83.0%). Over the past ten years it has ranged from 73.1% (fiscal 2016) to 83.0% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 73.0% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 83.0% | 1.73 |
| FY2024 | 81.3% | 2.06 |
| FY2023 | 79.3% | 2.48 |
| FY2022 | 76.8% | 2.59 |
| FY2021 | 74.2% | (3.48) |
| FY2020 | 77.7% | (1.19) |
| FY2019 | 78.9% | 0.63 |
| FY2018 | 78.2% | 0.49 |
| FY2017 | 77.7% | 4.64 |
| FY2016 | 73.1% | (1.67) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 83.9% | (1.90) |
| Jun 2026 | 85.8% | 3.85 |
| Mar 2026 | 81.9% | (0.60) |
| Dec 2025 | 82.5% | (0.38) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LLY Eli Lilly and Company | 83.6% |
| AZN AstraZeneca PLC compare | 81.9% |
| GILD Gilead Sciences, Inc. compare | 79.9% |
| NVS Novartis AG compare | 74.9% |
| ABBV AbbVie Inc. compare | 73.7% |
| PFE Pfizer Inc. compare | 73.4% |
| MRK Merck & Co., Inc. compare | 71.8% |
| AMGN Amgen Inc. compare | 70.9% |
| JNJ Johnson & Johnson compare | 67.6% |
| Drug Manufacturers General industry median | 73.0% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on LLY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement